Intel

Intel’s Insights from BioData World Congress 2016

One of our sponsors at BioData World Congress– Intel, prepared a post- event article with insights on the most burning topics that were discussed last week. Last week I was pleased to join a host of partners, customers and industry experts at the leafy Genome Campus in Cambridge, UK, for this year’s BioData World Congress. As one of the world’s leading …

Trials supported by electronic health records

Trials supported by electronic health records – a game-changer for study design and execution Professor Martin Gibson will be revealing the secrets of the successful delivery of GlaxoSmithKline’s (GSK) real world Salford Lung Study at BioData World Congress 2016 on 26 October in Cambridge. Widely recognised as the first study of its kind globally, the Salford Lung Study is a …

DNA Digest

Interview with Head of ELIXIR’s Human Genomics and Translational Data

Our supporting partner DNAdigest got in touch with one of our speakers at BioData World Congress– Serena Scollen, Head of Human Genomics and Translational Data at ELIXIR. Serena will be speaking about maximising opportunities to use human genomics data and about how ELIXIR enables this through European collaborations. We want to share some snippets of the interview and you will be able to access …

Rare diseases

Sharing the mission to conquer rare diseases

Closer collaboration between pharmaceutical companies and patient organizations will accelerate drug development At an ever-quickening pace, biopharmaceutical companies and patient advocacy groups are banding together to hasten development of new drugs for rare diseases. Advocacy groups rely on their partners for financial and scientific support while providing access to repositories of patient data – the key to understanding rare diseases …

Download: The New Frontier for the Pharmaceutical and Life Sciences Industry- Real Big Value from Big Data

  Technological growth and easy access to sophisticated gadgets have led to a digital data explosion. The life sciences industry is no exception, with its top priority being to improve the quality of human health and well being. Big Data helps achieve this by leveraging innovative techniques to enhance productivity in R&D, and reducing the cycle time for drug development …

Moving Towards Personalised Medicine with Big Data Strategies

  The use of Big Data strategies is thought to have the potential to help physicians and scientists move closer to treating individuals, rather than diseases. Developing treatments that are tailored to an individual’s history and sensitivities presents many challenges, and will only be possible within a digital health care system. An article from 20 January 2011 in the U.S. News & World …

Download: Kinapse on New Data Analytics for Pharma and Healthcare

An interview with Stephen Doogan on data integration and analytics for drug evaluation and patient experience McKinsey has predicted big data could reduce research and development costs for pharmaceutical makers by $40 billion to $70 billion. New analytics strategies are now changing companies’ ability to integrate, harmonize, derive and cross-validate insights from disconnected data at scale. Pharma companies who team up with …

Filling the Innovation Gap with Big Data

Data and information form the cornerstone of innovation, and it will take a change in mindset for the pharmaceutical industry to fill the innovation gap and change the way drug research is conducted. Drug approval has been flat for the last two decades, while the cost of drug development is constantly rising. Solid real world evidence of the drug performance …

Clinical Trials: Cooperation and Big Data Sharing is the Way Forward

Big Pharma companies are hiring Big Data analytics firms to protect privacy of shared data Important initiatives are emerging for big pharma companies to render their trials results accessible to other companies and to researchers. The spread of this tendency would make drug development more efficient and save the industry billions. Indeed, if researchers could always see which mistakes rivals …

big data big pharma

Announcing The Marriage of Big Pharma and Big Data

Novartis teams up with Google to develop “smart” lens This week a partnership between Goggle and Novartis has been announced, for the development of a “smart” contact lens to help diabetics track their blood sugar levels. This is the first big partnership made public between big pharma and big data to work together to revolutionise chronic disease monitoring and treatment. …